P
atients with surgically repaired coarctation of aorta (RCoA) are at increased cardiovascular mortality risk. Inflammation is an important element in RCoA.
1,2 Positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose ( 18 F-FDG) is the gold-standard imaging modality to noninvasively assess vascular inflammation in vivo. In this pilot study, we explore the value of 18 F-FDG PET/ CT imaging in assessing aortic wall inflammation in RCoA subjects.
A total of 15 patients with successful RCoA and 15 ageand sex-matched control subjects who have undergone treatment for lymphoma-a potentially high cardiovascular risk group-but were disease-free at the time of enrollment underwent 18 F-FDG PET/CT to evaluate aortic wall inflammation. RCoA patients also underwent measurement of arterial elastic properties (augmentation index and carotid-femoral pulse wave velocity) by SphygmoCor (AtCor Medical, Sydney, Australia). The central arterial blood pressure was derived from the use of a generalized transfer function. Plasma levels of IL-6 (interleukin-6), TGF-β (transforming growth factor-β), and macrophage colony-stimulating factor were determined as markers of systemic inflammation and aortic wall remodeling. Patients with hypercholesterolemia or diabetes mellitus were excluded. To test the hypothesis that aortic coarctation is associated with increased aortic wall inflammation even in the absence of adverse hemodynamic burden to the aorta, patients with recoarctation were also excluded from the study, which included only normotensive RCoA patients with no difference in systolic blood pressure compared with controls. The study was approved by the Institutional Ethics Committee, and informed consent was obtained from all participants.
Absence For PET/CT studies, the arterial target-to-background ratio (TBR) was calculated as mean arterial wall Standardized Uptake Value max to average value of superior vena cava Standardized Uptake Value mean for ascending, descending, and abdominal aorta, as well as their average, as global aortic TBR. RCoA patients had increased 18 F-FDG uptake globally in the aorta compared with control subjects ( In humans, increased vascular wall 18 F-FDG uptake has been associated with the risk of future cardiovascular events in subjects undergoing diagnostic PET imaging for clinical oncological indications. 3 In our study, we demonstrate for the first time that patients with RCoA have increased aortic wall inflammation as assessed by 18 F-FDG uptake compared with age-and sex-matched controls. This finding suggests that despite RCoA, hemodynamic burden early in life may have led to activation of proinflammatory signaling in the aortic wall and sustained increased inflammatory cell activity.
1,2 Altered aortic wall shear stress and, in particular, increased oscillatory shear stress in the descending aorta 4 could also partly explain the increased aortic FDG uptake in RCoA patients. Global aortic 18 F-FDG uptake was significantly increased in RCoA compared with control subjects (C). Regional differences in aortic FDG uptake in ascending, descending, and abdominal aorta between RCoA and control subjects (D). Association between aortic tissue to background ratio (TBR) and plasma IL-6 (interleukin-6) levels in RCoA patients (E, n=11). Association between aortic TBR and central mean aortic pressure (MAP) in RCoA patients; high: aortic TBR>median; low: aortic TBR<median (F). P values for (C), (D), and (F) were assessed by unpaired t test. PET/CT Imaging in Repaired Coarctation of Aorta Another interesting finding of our study is the strong association between aortic 18 F-FDG uptake and plasma levels of IL-6, a proinflammatory cytokine, which has predictive value for cardiovascular events in various populations. It has been previously demonstrated that RCoA patients have increased levels of proinflammatory mediators. We now extend these observations by demonstrating that there is a strong correlation between aortic wall inflammation and systemic lowgrade inflammatory response as assessed by plasma IL-6 levels. Furthermore, we report an important interaction between aortic wall inflammation and aorta hemodynamics. We demonstrate that RCoA patients with high aortic 18 F-FDG uptake have also higher central aortic pressures, suggesting that increased aortic wall metabolic activity could be related to hypertension development at a later stage in these subjects. The difference between groups in 18 F-FDG uptake may be modest and apparently smaller than that reported in some prior studies. 5 However, such discrepancies reflect not only differences in study populations and mechanisms related to elevated aortic 18 F-FDG uptake but also methodological differences between studies, which in the absence of standardized imaging protocols are inevitable.
In conclusion, our findings imply that aortic 18 F-FDG uptake could be a useful imaging biomarker in RCoA subjects. Aortic 18 F-FDG TBR could flag sustained aortic tissue inflammation late postoperatively during adult life and be predictive of aortopathy development. Considering the modest sample size and the limited statistical power of our study for a full analysis of the association of aortic 18 F-FDG uptake with aortic biomechanics (eg, arterial stiffening and aortic wall shear stress) or bicuspid aortic valve disease, these issues need to be further explored in larger clinical studies.
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